Literature DB >> 21061793

Expression of cytokines in cervical stroma in patients with high-grade cervical intraepithelial neoplasia after treatment with intralesional interferon alpha-2b.

M C Ramos1, M C Mardegan, B C Peghini, S J Adad, M A Michelin, E F C Murta.   

Abstract

Conservative treatment with interferons (IFNs) has the advantage of preserving reproductive capacity in patients with grade 2 or 3 cervical intraepithelial neoplasia (CIN). The objective of this work was to study patients with high-grade CIN treated with intralesional IFN alpha-2b and to analyze the expression of Th1, Th2 and Th3 cytokines in cervical stroma. We observed that patients with a satisfactory response (60%) to treatment with IFN alpha-2b expressed more Th1 (IFN-gamma TNF-alpha, IL-2) cytokines, with a significant reduction in the viral load of high-risk human papillomavirus (p = 0.0313). All patients with therapeutic failure were smokers and had higher expression of cytokines Th2 (IL-4) or Th3 (TGF-beta2 and TGF-beta3).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21061793

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  4 in total

1.  Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.

Authors:  Noy Ashkenazy; Carol L Karp; Gaofeng Wang; Carolina Mercado Acosta; Anat Galor
Journal:  Cornea       Date:  2017-04       Impact factor: 2.651

2.  Peripheral helper lymphocytes produce interleukin 12 in cancer patients.

Authors:  Márcia A Michelin; Douglas R Abdalla; André A R Aleixo; Eddie F C Murta
Journal:  Clin Med Insights Oncol       Date:  2013-03-06

3.  Challenging Treatment of Ocular Surface Squamous Neoplasia in Patients with Atopic Disease.

Authors:  Lily Zhang; Carolina Mercado; Anat Galor; Edward J Holland; Gaofeng Wang; Carol L Karp
Journal:  Ocul Immunol Inflamm       Date:  2017-11-30       Impact factor: 3.728

4.  Helper T lymphocyte response in the peripheral blood of patients with intraepithelial neoplasia submitted to immunotherapy with pegylated interferon-α.

Authors:  Márcia Antoniazi Michelin; Letícia Montes; Rosekeila Simões Nomelini; Marco Aurélio Trovó; Eddie Fernando Candido Murta
Journal:  Int J Mol Sci       Date:  2015-03-10       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.